Delivery Order SPE2DR25D3501-SPE2DR26FM2PE
Award Date 1/15/26
Potential Completion Date 1/16/26
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,813.12 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units). This competitively awarded, firm fixed price contract was executed on December 16, 2025, with an ultimate completion date of December 17, 2025. The contract is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $17,820.21 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units) with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mesalamine is a pharmaceutical treatment primarily used for inflammatory bowel...
- The Defense Logistics Agency awarded a $4,928.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units), with performance in Conshohocken, Pennsylvania and a completion deadline of December 2, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion ceiling...
- The Defense Logistics Agency awarded a delivery order valued at $27,922.67 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units) with a firm fixed price structure. The contract is non-competitive and represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The place of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Mesalamine DR 400 mg capsules. The $1,918.44 firm-fixed-price contract has an ultimate completion date of September 19, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mesalamine ER 0.375 gram capsules (120-count). This is a firm fixed price delivery order with a ceiling value of $7,754.63 and an ultimate completion date of September 9, 2025. The award represents a non-competitive procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,417.46 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This non-competitive, firm fixed-price delivery order was awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a $17,647.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 400 mg capsules (180 count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mesalamine is a therapeutic medication used primarily to treat inflammatory bowel conditions, and this...
- The Defense Logistics Agency awarded a delivery order valued at $1,250.30 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180 count) under a firm fixed-price contract. The award, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,619.57 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units). This contract type is a firm fixed-price delivery order with no set-aside designation, executed on June 17, 2025, with an ultimate completion date of June 18, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...